INS and Insulin resistance: Included in this decline is a redistribution of fat from subcutaneous to visceral depots, particularly in post-menopausal women, which is associated with an increased risk for metabolic dysfunction, including insulin resistance (IR), as adipose tissue releases excess FFA and inflammatory mediators that impair insulin signaling (32, 33).